Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4507153
Author(s) Valent, Peter; Akin, Cem; Bonadonna, Patrizia; Hartmann, Karin; Brockow, Knut; Niedoszytko, Marek; Nedoszytko, Boguslaw; Siebenhaar, Frank; Sperr, Wolfgang R.; Oude Elberink, Joanna N. G.; Butterfield, Joseph H.; Alvarez-Twose, Ivan; Sotlar, Karl; Reiter, Andreas; Kluin-Nelemans, Hanneke C.; Hermine, Olivier; Gotlib, Jason; Broesby-Olsen, Sigurd; Orfao, Alberto; Horny, Hans-Peter; Triggiani, Massimo; Arock, Michel; Schwartz, Lawrence B.; Metcalfe, Dean D.
Author(s) at UniBasel Hartmann, Karin
Year 2019
Title Proposed diagnostic algorithm for patients with suspected mast cell activation syndrome
Journal The Journal of Allergy and Clinical Immunology: In Practice
Volume 7
Number 4
Pages / Article-Number 1125-1133.e1
Mesh terms Algorithms; Diagnosis, Differential; Humans; Hypersensitivity, Immediate, physiopathology; Mastocytosis, physiopathology; Mastocytosis, Systemic, physiopathology; Proto-Oncogene Proteins c-kit, genetics; Tryptases, metabolism
Abstract Mast cell activation (MCA) accompanies diverse physiologic and pathologic processes and is one of the more frequently encountered conditions in medicine. MCA-related symptoms are usually mild and often transient. In such cases, histamine receptor blockers and other mediator-targeting drugs can usually control MCA. In severe cases, an MCA syndrome (MCAS) may be diagnosed. However, overt MCAS is an unusual condition, and many patients referred because of suspected MCAS are diagnosed with other diseases (autoimmune, neoplastic, or infectious) unrelated to MCA or suffer from MCA-related (eg, allergic) disorders and/or comorbidities without fulfilling criteria of an overt MCAS. These considerations are important as more and more patients are informed that they may have MCA or even MCAS without completing a thorough medical evaluation. In fact, in several instances, symptoms are misinterpreted as MCA/MCAS, and other clinically relevant conditions are not thoroughly pursued. The number of such referrals is increasing. To avoid such unnecessary referrals and to prevent misdiagnoses, we here propose a diagnostic algorithm through which a clinically relevant (systemic) MCA can be suspected and MCAS can subsequently be documented or excluded. In addition, the algorithm proposed should help guide the investigating care providers to consider the 2 principal diagnoses that may underlie MCAS, namely, severe allergy and systemic mastocytosis accompanied by severe MCA. Although validation is required, we anticipate that this algorithm will facilitate the management of patients with suspected MCAS.
Publisher Elsevier
ISSN/ISBN 2213-2201
URL http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6643056/
edoc-URL https://edoc.unibas.ch/70715/
Full Text on edoc No
Digital Object Identifier DOI 10.1016/j.jaip.2019.01.006
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/30737190
ISI-Number WOS:000463732500004
Document type (ISI) Journal Article, Review
 
   

MCSS v5.8 PRO. 0.376 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
29/03/2024